文献速递甲状腺疾病

大型非浸润性滤泡型甲状腺肿瘤伴乳头状核特征的治疗结局

Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
PubMed 文献 · Thyroid · 2017-02-24

本研究回顾四个三级医院病理数据库中的79例大型(≥4 cm)非浸润性滤泡型甲状腺肿瘤伴乳头状核特征(NIFTP)病例,中位肿瘤大小4.5 cm,无一例复发,包括未接受放射性碘治疗者;结论认为大型NIFTP复发风险极低,单纯手术治疗(包括腺叶切除)似乎已足够。

要点

  • 大型NIFTP中位大小4.5 cm,女性多见(男:女=1:1.8),中位年龄49岁。
  • 全部队列无一例复发,包括32例随访≥2年且未接受放射性碘治疗者(中位随访6.7年)。
  • 随访≥4年的25例未接受放射性碘治疗者均无复发,中位随访11.2年。

核心结论

  • 大型NIFTP与小NIFTP相似,复发风险极低(本队列为零),即使保守治疗未行放射性碘治疗。
  • 单纯手术治疗(包括腺叶切除)似乎足以治疗大型NIFTP。

研究设计与样本

  • 回顾四个三级医院病理数据库,纳入79例大型(≥4 cm)NIFTP,排除存在独立癌灶的病例。
  • 56例(71%)有至少2年临床随访,49例(62%)有4年或以上随访。
  • 临床病理特征由四位内分泌病理学家审阅记录。

主要发现

  • NIFTP中位大小4.5 cm(范围4.0–8.0 cm)。
  • 50例(63%)肿瘤整个包膜被取材,其余29例(37%)代表性取材,每厘米肿瘤中位检查2.1个蜡块。
  • 男:女比例为1:1.8,中位年龄49岁。
  • 诊断时无一例淋巴结转移,25例有淋巴结组织可供显微镜检查者均无阳性发现。
  • 26例(33%)仅行甲状腺腺叶切除,37例(47%)未接受放射性碘消融。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2016, encapsulated follicular variant of papillary thyroid carcinoma without invasion was renamed "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" (NIFTP) in order to reduce overtreatment of this indolent tumor. However, many endocrinologists remain uneasy about managing large (≥4 cm) NIFTP conservatively without radioactive iodine (RAI) therapy. The objectives of this study are to characterize the clinicopathologic characteristics and outcome of large NIFTP in order to assist therapeutic decision making. METHODS: The pathology databases of four tertiary hospitals were searched for large (≥4 cm) NIFTP. Cases with separate foci of carcinoma were excluded. Seventy-nine cases fulfilled the inclusion criteria. Among them, 56 (71%) had at least two years of clinical follow-up (FU), and 49 (62%) had four or more years of FU. The clinicopathologic characteristics were reviewed and documented by four endocrine pathologists. RESULTS: The median size of the NIFTP was 4.5 cm (range 4.0-8.0 cm). The entire capsule was sampled in 50 (63%) tumors, while in the remaining 29 (37%) cases, it was submitted representatively, with a median of 2.1 blocks per centimeter of tumor examined. Large NIFTP had a female preponderance with a male:female ratio of 1:1.8, and presented at a median age of 49 years. There were no lymph node metastases at diagnosis in any of the patients, and none of the patients (n = 25) in whom nodal tissue was available for microscopic examination had positive findings. Twenty-six (33%) underwent thyroid lobectomy alone, and 37 (47%) did not receive RAI ablation. No recurrence was observed in the entire cohort, including all 32 patients with two or more years of FU who did not receive RAI therapy (median FU: 6.7 years). Among patients with four or more years of FU, all 25 individuals without RAI therapy did not recur, with a median FU of 11.2 years. Patients with a larger tumor size tended to receive postoperative RAI ablation (p = 0.001). CONCLUSIONS: Similar to their small counterparts, large NIFTP appear to have an extremely low risk of recurrence (zero in this cohort), even when treated conservatively without RAI therapy. Surgical treatment alone, including lobectomy, appears to be adequate for large NIFTP.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Xu B, Tallini G, Scognamiglio T, et al. Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid. 2017. PMID: 28136139. doi:10.1089/thy.2016.0649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。